The Analyst
Cure8 research brief
Why This Matters
The study tests a molecular technique (ATR-FTIR) with machine learning on biopsy tissue to find signals linked to future dysplasia/CRC risk in IBD — a potential complement to colonoscopic surveillance if validated.
Who Should Pay Attention
Clinicians and researchers focused on IBD surveillance and biomarker development; patients interested in emerging risk-assessment tools for IBD-related colorectal cancer.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
Researchers used ATR-FTIR (mid-infrared spectroscopy) on archived endoscopic biopsy samples from 30 IBD patients (10 who later developed dysplasia, 20 who did not). They applied chemometrics and machine learning (including PCA, hierarchical clustering, and PLS-based classifiers) to look for spectral differences associated with later dysplasia.
The authors report that spectral features—notably in a lipid-associated region (2950–3030 cm–1)—carry information related to long-term CRC risk, but classifiers trained on this cohort did not perform significantly above chance after permutation testing.
The paper presents the approach as hypothesis-generating and complementary to current surveillance rather than a ready diagnostic test.
Keep In Mind
Small sample size (30 patients) and lack of classifier performance above chance in permutation testing mean findings are preliminary; the paper frames the work as hypothesis-generating and needing larger validation cohorts.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationThe Analyst
AuthorsEric Kumi-Barimah, Raneem Toman, Animesh Jha +2 more
InstitutionSchool of Chemical and Process Engineering, University of Leeds, Leeds, LS2 9JT, UK. E.Kumi-Barimah@leeds.ac.uk.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedSep 14, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Machine learning-driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.
The study suggests specific bile-acid–related genes that are altered in UC and linked to immune-cell changes, which could help researchers and clinicians exploring new biomarkers or mechanisms behind inflammation in UC.
Generative AI Helps Spot Crohn's Bowel Scarring Early
The study uses generative AI and microbiome/RNA data to search for biomarkers of intestinal fibrosis in Crohn’s disease, which could help spot scarring earlier and potentially prevent worsening complications like...
Microbiota Dynamics in Crohn's Disease Recurrence - Docwire News
Postoperative recurrence after ileal resection is common in Crohn’s disease; understanding microbial changes linked to recurrence could help explain mechanisms and guide future biomarker development.